216 CHAPTER 3.1 17. O’Sullivan D, O’Mahony D, O’Connor M, Gallagher P, Gallagher J, Cullinan S, et al. Prevention of adverse drug reactions in hospitalised older patients using a softwaresupported structured pharmacist intervention: a cluster randomised controlled trial. Drugs Aging. 2016;33(1):63–73. 18. Drenth-van Maanen C, Leendertse A, Jansen PA, Knol W, Keijsers CJP, Meulendijk M, et al. The systematic tool to reduce inappropriate prescribing (STRIP): combining implicit and explicit prescribing tools to improve appropriate prescribing. J Eval Clin Pract. 2018;24(2):317–322. 19. Meulendijk MC, Spruit MR, Drenth-vanMaanen AC, Numans ME, Brinkkemper S, Jansen PAF, et al. Computerized decision support improves medication review effectiveness: an experiment evaluating the STRIP Assistant’s usability. Drugs Aging. 2015;32(6):495–503. 20. Shen Z, Meulendijk M, Spruit M. Prototypes, 2. 2016. A federated information architecture for multinational clinical trials: STRIPA revisited. 21. Dalton K, O’Brien G, O’Mahony D, Byrne S. Computerised interventions designed to reduce potentially inappropriate prescribing in hospitalised older adults: a systematic review and meta-analysis. Age Ageing. 2018;47(5):1–9. 22. Verdoorn S, Kwint HF, Hoogland P, Gussekloo J, Bouvy ML. Drug-related problems identified during medication review before and after the introduction of a clinical decision support system. J Clin Pharm Ther. 2018;43(2):224–231. 23. Verdoorn S, Kwint HF, Faber A, Gussekloo J, Bouvy ML. Majority of drug-related problems identified during medication review are not associated with STOPP/START criteria. Eur J Clin Pharmacol. 2015;71(10):1255–1262. 24. Beuscart JB, Knol W, Cullinan S, Schneider C, Dalleur O, Boland B, et al. International core outcome set for clinical trials of medication review in multi-morbid older patients with polypharmacy. BMC Med. 2018;16(1):1–9. 25. Adam L, Moutzouri E, Baumgartner C, Loewe AL, Feller M, M’Rabet-Bensalah K, et al. Rationale and design of OPtimising thERapy to prevent avoidable hospital admissions in multimorbid older people (OPERAM): a cluster randomised controlled trial. BMJ Open. 2019;9(6):e026769. 26. Andersen SE, Pedersen AB, Bach KF. Medication history on internal medicine wards: assessment of extra information collected from second drug interviews and GP lists. Pharmacoepidemiol Drug Saf. 2003;12(6):491–498. 27. Atkin P, Stringer R, Duffy J, Elion C, Ferraris C, Misrachi S, et al. The influence of information provided by patients on the accuracy of medication records. Med J Aust. 1998;169(2):85–88. 28. Drenth-van Maanen C, Spee J, Van Hensbergen L, Jansen PAF, Egberts T, van Marum RJ. Structured history-taking of medication use reveals iatrogenic harm due to discrepancies in medication histories in hospital and pharmacy records. J Am Geriatr Soc. 2011;59(10):1976–1978. 29. Prins M, Drenth-van Maanen C, Kok R, Jansen P. Use of a structured medication history to establish medication use at admission to an old age psychiatric clinic: a prospective observational study. CNS Drugs. 2013;27(11):963–969. 30. Tam VC, Knowles SR, Cornish PL, Fine N, Marchesano R, Etchells EE. Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review. Cmaj. 2005;173(5):510–515. 31. Fitzgerald RJ. Medication errors: the importance of an accurate drug history. Br J Clin Pharmacol. 2009;67(6):671–675. 32. Unroe K, Pfeiffenberger T. Inpatient medication reconciliation at admission and discharge: a retrospective cohort study of age and other risk factors for medication discrepancies. Am J Geriatr Pharmacother. 2010;8(2):17–29.
RkJQdWJsaXNoZXIy MTk4NDMw